Ovarian cancer test news is misunderstood says gynaecological cancer charity The Eve Appeal
In light of recent media coverage following the introduction of new NICE guidelines on ovarian cancer, The Eve Appeal and UCL Gynaecology Cancer Research Centre are concerned that women are misunderstanding the advice recently reported on CA125 blood tests.Says Robert Marsh, CEO at The Eve Appeal “ The CA125 is an existing blood test currently available on the NHS to patients who have, or are suspected of having, ovarian cancer. Our concern is that women’s perception of the NICE guidelines as reported in the media is that this is a new test available for £20 to women who want to check that